Editas Medicine Inc. (EDIT)
NASDAQ: EDIT
· Real-Time Price · USD
3.01
0.05 (1.69%)
At close: Aug 15, 2025, 2:59 PM
Editas Medicine Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 35.32M | 35.84M | 32.31M | 61.76M | 67.03M | 69.41M | 78.12M | 24.61M | 19.32M | 22.79M | 19.71M | 25.64M | 31.8M | 25.82M | 25.54M | 24.49M | 81.14M | 91.51M |
Cost of Revenue | 3.89M | 5.31M | 5.81M | 5.89M | 5.81M | 5.93M | 6.06M | 6.17M | 6.26M | 6.32M | 6.34M | 6.27M | 33.93M | 66.09M | 106.47M | 166.46M | 171.11M | 165.36M |
Gross Profit | 32.34M | 31.44M | 26.5M | 55.86M | 61.22M | 63.48M | 72.06M | 18.43M | 13.05M | 16.47M | 13.37M | 19.37M | -2.13M | -40.27M | -80.92M | -141.97M | -89.97M | -73.86M |
Operating Income | -188.42M | -260.32M | -251.15M | -228.52M | -213.02M | -185.21M | -169.18M | -208.66M | -216.02M | -226.16M | -225.95M | -204.11M | -185.85M | -187.01M | -193.15M | -217.41M | -169.17M | -145.11M |
Interest Income | 7.45M | 11.74M | 14.06M | 17.96M | 19.58M | 19.09M | 17.57M | 13.88M | 10.53M | 7.27M | 4.23M | 4.72M | 3.08M | 2.68M | 2.34M | 660K | 734K | 1.18M |
Pretax Income | -236.86M | -251.23M | -237.09M | -210.57M | -193.45M | -166.13M | -153.22M | -195.08M | -205.79M | -218.95M | -220.43M | -201.13M | -184.49M | -186.29M | -192.5M | -213.56M | -166.66M | -134.98M |
Net Income | -236.86M | -251.23M | -237.09M | -210.57M | -193.45M | -166.13M | -149.75M | -185.91M | -194.82M | -207.21M | -211.92M | -198.32M | -183.47M | -186.05M | -192.5M | -213.56M | -166.66M | -134.98M |
Selling & General & Admin | 60.68M | 66.02M | 71.99M | 70.09M | 66.99M | 65.98M | 69.65M | 73.18M | 74.43M | 74.17M | 70.7M | 69.24M | 69.19M | 74.28M | 76.18M | 75.44M | 79.2M | 71.25M |
Research & Development | 126.42M | 175.63M | 196.42M | 215.9M | 173.59M | 150.58M | 141.01M | 124.92M | 160.91M | 174.79M | 174.96M | 160.51M | 148.45M | 138.55M | 142.51M | 166.46M | 171.11M | 165.37M |
Other Expenses | 41.56M | 2.88M | -37.98M | -1.6M | 33.66M | 33.66M | 32.07M | 33.36M | -301K | -59K | 1.29M | -323K | -305K | -1.05M | -794K | 2.38M | 969K | 8.65M |
Operating Expenses | 228.66M | 244.53M | 230.43M | 284.39M | 274.24M | 250.23M | 244.32M | 231.76M | 235.34M | 248.95M | 245.66M | 229.76M | 217.65M | 212.83M | 218.69M | 241.91M | 250.31M | 236.62M |
Interest Expense | 2.22M | 2.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 223.75M | 296.16M | 283.47M | 290.28M | 280.05M | 254.62M | 247.3M | 233.27M | 235.34M | 248.95M | 245.66M | 229.76M | 217.65M | 212.83M | 218.69M | 241.91M | 250.31M | 236.62M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -3.47M | -9.17M | -10.97M | -11.75M | -8.51M | -2.81M | -1.17M | -387K | -152K | -152K | n/a | n/a |
Shares Outstanding (Basic) | 84.41M | 83.06M | 82.61M | 82.49M | 82.31M | 81.94M | 81.71M | 81.65M | 71.38M | 68.92M | 68.79M | 68.74M | 68.64M | 68.26M | 68.36M | 68.22M | 67.88M | 65.99M |
Shares Outstanding (Diluted) | 84.41M | 83.06M | 82.61M | 82.49M | 82.31M | 81.94M | 81.71M | 81.65M | 71.38M | 68.92M | 68.79M | 68.74M | 68.64M | 68.48M | 68.36M | 68.22M | 67.88M | 65.99M |
EPS (Basic) | -2.85 | -3.04 | -2.88 | -2.56 | -2.36 | -2.1 | -2 | -2.57 | -2.8 | -3.01 | -3.09 | -2.9 | -2.69 | -2.73 | -2.85 | -3.25 | -2.55 | -2.17 |
EPS (Diluted) | -2.85 | -3.04 | -2.88 | -2.56 | -2.36 | -2.1 | -2 | -2.57 | -2.8 | -3.01 | -3.08 | -2.89 | -2.68 | -2.72 | -2.85 | -3.24 | -2.55 | -2.17 |
EBITDA | -176.51M | -246.99M | -240.62M | -219.1M | -207.21M | -179.28M | -163.12M | -202.49M | -209.76M | -219.84M | -219.61M | -197.84M | -179.99M | -181.57M | -188.09M | -212.68M | -164.53M | -140.78M |
EBIT | -181.41M | -253.31M | -246.43M | -225M | -213.02M | -185.21M | -169.18M | -208.66M | -216.02M | -226.16M | -225.95M | -204.11M | -185.85M | -187.01M | -193.15M | -217.41M | -169.17M | -145.1M |
Depreciation & Amortization | 4.9M | 6.32M | 5.81M | 5.89M | 5.81M | 5.93M | 6.06M | 6.17M | 6.26M | 6.32M | 6.34M | 6.27M | 5.86M | 5.45M | 5.05M | 4.72M | 4.64M | 4.32M |